Evidence map›Paper›PMID 39291278›Full record

SynthesisFrontiers in transplantation2024

The role of C4d and donor specific antibodies in face and hand transplantation-a systematic review.

Lioba Huelsboemer, Jake Moscarelli, Alna Dony, Sam Boroumand, Alejandro Kochen, Leonard Knoedler, Catherine T Yu, Sacha C Hauc, Viola A Stögner, Richard N Formica and 4 more

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in transplantation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Ten-year follow-up after face transplantation-A single-center retrospective cohort study.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2025
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Lioba Huelsboemer *Division of Reconstructive and Plastic Surgery, Yale School of Medicine, New Haven, CT, United States.
Jake Moscarelli *Division of Reconstructive and Plastic Surgery, Yale School of Medicine, New Haven, CT, United States.
Alna DonyDivision of Reconstructive and Plastic Surgery, Yale School of Medicine, New Haven, CT, United States.
Sam BoroumandDivision of Reconstructive and Plastic Surgery, Yale School of Medicine, New Haven, CT, United States.
Alejandro KochenDivision of Reconstructive and Plastic Surgery, Yale School of Medicine, New Haven, CT, United States.
Leonard KnoedlerDivision of Reconstructive and Plastic Surgery, Yale School of Medicine, New Haven, CT, United States.
Catherine T YuDivision of Reconstructive and Plastic Surgery, Yale School of Medicine, New Haven, CT, United States.
Sacha C HaucDivision of Reconstructive and Plastic Surgery, Yale School of Medicine, New Haven, CT, United States.
Viola A StögnerDivision of Reconstructive and Plastic Surgery, Yale School of Medicine, New Haven, CT, United States.
Richard N FormicaDepartment of Medicine, Section of Nephrology and Transplantation, Yale School of Medicine, New Haven, CT, United States.
Christiane G LianProgram in Dermatopathology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Georg F MurphyProgram in Dermatopathology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Bohdan PomahacDivision of Reconstructive and Plastic Surgery, Yale School of Medicine, New Haven, CT, United States.
Martin Kauke-NavarroDivision of Reconstructive and Plastic Surgery, Yale School of Medicine, New Haven, CT, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To date, little is known about the mechanisms of rejection in vascularized composite allotransplantation, particularly for antibody mediated rejection. Additionally, no clear guidelines exist for the diagnosis and management of antibody-mediated rejection in vascularized composite allotransplantation. A systematic review of electronic databases (Embase and PubMed) was conducted to evaluate the relationship of donor specific antibodies and C4d deposition in correlation with cellular rejection following hand and face transplantation reported by centers between 1998 and July 2023. We extracted data on serum donor specific antibodies at the time of biopsy proven rejection according to Banff classification and C4d staining of target tissues. Mann-Whitney U tests were performed to compare rejection grade between groups divided by status of C4d deposition and serum donor specific antibodies, and Fisher's Exact test was used to assess association between the two markers. This review adhered to PRISMA guidelines. A total of 26 patients (5 face, 21 hand) were identified and data on 90 acute rejection episodes with information on Banff grade, donor specific antibody status, and C4d deposition were available. Donor specific antibodies were found to be associated with higher rejection grade (

Indexed as

antibody-mediated rejectionC4ddonor specific antibodyreconstructive surgeryvascularized composite allotransplantationVCA

Identifiers

PMID39291278
PMCPMC11405992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.